10-Q quarterly report · filed Apr 30, 2026

Teladoc Health, Inc. (TDOC) Q1 2026 10-Q Quarterly Report

Short answer

Teladoc Health, Inc. (TDOC) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $614M (down 2.5% year over year) with net income of −$64M.

Q1 2026 key financials · XBRL

Revenue
$614M
−2.5% YoY
Net income
−$64M
+31.4% YoY
Operating margin
-10.1%
EPS (diluted)
−$0.36
+32.1% YoY

Source: XBRL data from the Teladoc Health, Inc. (TDOC) Q1 2026 10-Q on SEC EDGAR. USD.

Teladoc Health, Inc. Q1 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $613.8M, down 2% YoY from $629.4M, driven by lower BetterHelp revenue
  • Net loss $63.8M vs $93.0M; loss from operations $61.8M vs $120.6M
  • Integrated Care revenue $395.4M, up 2% YoY; BetterHelp paying users 0.361M, down 9%
  • Adjusted EBITDA $58.2M vs $58.1M; Integrated Care $56.3M vs BetterHelp $1.9M
  • Restructuring costs $12.0M; full-year 2026 outlook $15.0M-$20.0M in pre-tax costs

Risk Factors

  • No substantive risk-factor disclosure provided in the excerpt
  • No newly added risk identified because the filing text contains only Items 5–6 and signatures
  • No updated regulatory, legal, operational, competitive, or financial risk details availableмилаҭ

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Teladoc Health, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.